Treatment validation systems and methods

US10098785B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10098785-B2
Application numberUS-201615294070-A
CountryUS
Kind codeB2
Filing dateOct 14, 2016
Priority dateMar 18, 2011
Publication dateOct 16, 2018
Grant dateOct 16, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Treatment validation techniques include generating a modified treatment target from an original treatment target using a modification process, and comparing induced aberrations provided by the original and modified treatment targets, so as to verify the modified treatment target or the modification process. In some cases, a modification process may include a deconvolution process, a low pass filter process, a scaling process, or an adjustment process. The induced aberrations may include high order aberrations, such as spherical aberration.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for determining a vision treatment for an eye of a patient, the system comprising: an input that receives an original target profile for the eye of the patient; a processor; and computer executable code stored on a non-transitory computer readable medium, the computer executable code comprising instructions that when executed by the processor cause the processor to determine a deconvolved target profile based on the original target profile and a low pass filter, to determine a scaled target profile based on the deconvolved target profile and a scale factor, and to determine the vision treatment based on the scaled target profile, wherein the scale factor is based on a low order refraction measure of a test eye population and a low order refraction measure of a convolved test eye population profile, and wherein the convolved test eye population profile is based on a convolution of the test eye population profile. 2. The system according to claim 1 , wherein the low pass filter is an optimized linear filter. 3. The system according to claim 1 , wherein the scale factor has a value within a range from about 0.4 to about 0.8. 4. The system according to claim 1 , wherein the scale factor has a value of about 0.7489. 5. The system according to claim 1 , wherein the low order refraction measure of the test eye population profile comprises a first manifest refraction spherical equivalent measure and the low order refraction measure of the convolved test eye population profile comprises a second manifest refraction spherical equivalent measure. 6. The system according to claim 5 , wherein the first manifest refraction spherical equivalent measure is a 4 mm refraction measure and the second manifest refraction spherical equivalent measure is a 4 mm refraction measure. 7. A system for determining a vision treatment for an eye of a patient, the system comprising: an input that receives an original target profile for the eye of the patient; a processor; and computer executable code stored on a non-transitory computer readable medium, the computer executable code comprising instructions that when executed by the processor cause the processor to determine a first low order refraction measure based on the original target profile, to determine a deconvolved target profile based on the original target profile and a low pass filter, to determine a second low order refraction measure based on the deconvolved target profile, to determine a scale factor based on a comparison between the first low order refraction measure and the second low order refraction measure, to determine a scaled target profile based on the deconvolved target profile and the scale factor, and to determine the vision treatment based on the scaled target profile. 8. The system according to claim 7 , wherein the first low order refraction measure comprises a first manifest refraction spherical equivalent measure and the second low order refraction measure comprises a second manifest refraction spherical equivalent measure. 9. The system according to claim 8 , wherein the first manifest refraction spherical equivalent measure is a 4 mm refraction measure and the second manifest refraction spherical equivalent measure is a 4 mm refraction measure. 10. The system according to claim 7 , wherein the first low order refraction measure comprises a first sphere measure and the second low order refraction measure comprises a second sphere measure. 11. The system according to claim 7 , wherein the first low order refraction measure comprises a first cylinder measure and the second low order refraction measure comprises a second cylinder measure. 12. A system for determining a vision treatment for an eye of a patient, the system comprising: an input that receives an original target profile for the eye of the patient; a processor; and computer executable code stored on a non-transitory computer readable medium, the computer executable code comprising instructions that when executed by the processor cause the processor to determine a first healed profile based on the original target profile, to determine a deconvolved target profile based on the original target profile and a low pass filter, to determine a second healed profile based on the deconvolved target profile, to determine a first low order refraction measure based on the first healed profile, to determine a second low order refraction measure based on the second healed profile, to determine a scale factor based on a comparison between the first and second low order refraction measures, to determine a scaled target profile based on the deconvolved target profile and the scale factor, and to determine the vision treatment based on the scaled target profile. 13. The system according to claim 12 , wherein the first low order refraction measure comprises a first manifest refraction spherical equivalent measure and the second low order refraction measure comprises a second manifest refraction spherical equivalent measure. 14. The system according to claim 13 , wherein the first manifest refraction spherical equivalent measure is a 4 mm refraction measure and the second manifest refraction spherical equivalent measure is a 4 mm refraction measure. 15. The system according to claim 12 , wherein the first low order refraction measure comprises a first sphere measure and the second low order refraction measure comprises a second sphere measure. 16. The system according to claim 12 , wherein the first low order refraction measure comprises a first cylinder measure and the second low order refraction measure comprises a second cylinder measure. 17. A system for determining a vision treatment for an eye of a patient, the system comprising: an input that receives an original target profile for the eye of the patient; a processor; and computer executable code stored on a non-transitory computer readable medium, the computer executable code comprising instructions that when executed by the processor cause the processor to determine a deconvolved target profile based on the original target profile and a low pass filter, to determine a scaled target profile based on the deconvolved target profile and a scale factor, to adjust a sphere parameter of the scaled target profile based on a pre-operative cylinder measurement of the eye of the patient, and to determine the vision treatment based on the adjusted target profile, wherein the scale factor is based on a low order refraction measure of a test eye population and a low order refraction measure of a convolved test eye population profile, and wherein the convolved test eye population profile is based on a convolution of the test eye population profile. 18. The system according to claim 17 , wherein the pre-operative cylinder measurement is a manifest refraction measurement. 19. The system according to claim 17 , wherein the pre-operative cylinder measurement is a wavefront refraction measurement. 20. The system according to claim 17 , wherein the adjusted sphere parameter of the scaled target profile is determined based on the formula S=−0.28 C−0.38, where S is the adjusted sphere parameter and C is the pre-operative cylinder measurement.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10098785B2 cover?
Treatment validation techniques include generating a modified treatment target from an original treatment target using a modification process, and comparing induced aberrations provided by the original and modified treatment targets, so as to verify the modified treatment target or the modification process. In some cases, a modification process may include a deconvolution process, a low pass fi…
Who is the assignee on this patent?
Amo Dev Llc
What technology area does this patent fall under?
Primary CPC classification A61F9/00804. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).